This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Osaka University, Rohto Pharmaceutical Co., Ltd.. Active years: 2022.
Company Filing History:
1 out of 1,040 
1 out of 82 
Years Active: 2022
Title: The Innovations of Ryuuhei Hayashi
Introduction
Ryuuhei Hayashi is a notable inventor based in Suita, Japan. He has made significant contributions to the field of regenerative medicine, particularly in the area of corneal health. His work focuses on the use of mesenchymal stem cell-derived microparticles to promote the growth and maintenance of corneal epithelial cells.
Latest Patents
Hayashi holds a patent for "Mesenchymal stem cell-derived exosome." This invention relates to microparticles derived from mesenchymal stem cells that have the ability to promote the growth of corneal epithelial stem cells and maintain them in an undifferentiated state. Additionally, these microparticles help protect the corneal epithelium, showcasing their potential in therapeutic applications.
Career Highlights
Throughout his career, Ryuuhei Hayashi has worked with prestigious institutions, including Osaka University and Rohto Pharmaceutical Co., Ltd. His research has contributed to advancements in understanding how stem cells can be utilized for ocular health.
Collaborations
Hayashi has collaborated with notable colleagues such as Kohji Nishida and Yoichi Honma. Their combined expertise has furthered research in the field of stem cell applications in medicine.
Conclusion
Ryuuhei Hayashi's innovative work in mesenchymal stem cell-derived microparticles represents a significant advancement in regenerative medicine. His contributions have the potential to improve treatments for corneal health and enhance patient outcomes.